Allstate’s (ALL) “Neutral” Rating Reaffirmed at The Goldman Sachs Group

The Goldman Sachs Group reissued their neutral rating on shares of Allstate (NYSE:ALL) in a research note published on Thursday morning, MarketBeat.com reports. The firm currently has a $231.00 target price on the insurance provider’s stock.

Other equities research analysts also recently issued reports about the stock. Mizuho lifted their price objective on shares of Allstate from $255.00 to $281.00 and gave the stock an “outperform” rating in a research note on Monday, February 9th. Citigroup raised their target price on shares of Allstate from $216.00 to $221.00 and gave the stock a “neutral” rating in a report on Tuesday, February 10th. TD Cowen downgraded Allstate from a “buy” rating to a “hold” rating in a research note on Monday, January 12th. Raymond James Financial reiterated a “strong-buy” rating and set a $260.00 price target on shares of Allstate in a research report on Tuesday. Finally, Wells Fargo & Company lowered their price target on shares of Allstate from $228.00 to $227.00 and set an “equal weight” rating on the stock in a report on Friday, February 20th. Three analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Allstate has a consensus rating of “Moderate Buy” and a consensus price target of $238.88.

Allstate Trading Down 1.2%

Shares of NYSE:ALL opened at $211.58 on Thursday. The business’s 50-day moving average is $204.56 and its 200 day moving average is $204.70. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.37 and a quick ratio of 0.37. Allstate has a 1 year low of $176.00 and a 1 year high of $216.75. The firm has a market capitalization of $54.91 billion, a P/E ratio of 5.54, a P/E/G ratio of 0.44 and a beta of 0.23.

Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, February 4th. The insurance provider reported $14.31 EPS for the quarter, beating the consensus estimate of $8.72 by $5.59. The firm had revenue of $17.35 billion during the quarter, compared to analyst estimates of $17.23 billion. Allstate had a net margin of 15.19% and a return on equity of 39.20%. Allstate’s revenue was up 5.1% on a year-over-year basis. During the same period last year, the firm posted $7.67 EPS. On average, research analysts predict that Allstate will post 18.74 earnings per share for the current fiscal year.

Allstate Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $1.08 dividend. This represents a $4.32 annualized dividend and a yield of 2.0%. This is a positive change from Allstate’s previous quarterly dividend of $1.00. The ex-dividend date of this dividend is Monday, March 2nd. Allstate’s dividend payout ratio is 11.31%.

Insider Activity

In other Allstate news, insider Suren Gupta sold 19,593 shares of the firm’s stock in a transaction on Wednesday, January 7th. The stock was sold at an average price of $210.00, for a total value of $4,114,530.00. Following the sale, the insider directly owned 100,646 shares in the company, valued at $21,135,660. This trade represents a 16.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.70% of the company’s stock.

Institutional Trading of Allstate

A number of large investors have recently bought and sold shares of the business. Brighton Jones LLC lifted its holdings in shares of Allstate by 60.2% during the fourth quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock worth $1,253,000 after purchasing an additional 2,443 shares during the period. Revolve Wealth Partners LLC acquired a new position in Allstate in the fourth quarter valued at $231,000. GPS Wealth Strategies Group LLC increased its stake in shares of Allstate by 4.2% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 3,808 shares of the insurance provider’s stock valued at $767,000 after acquiring an additional 155 shares during the last quarter. Moors & Cabot Inc. boosted its position in shares of Allstate by 0.7% in the second quarter. Moors & Cabot Inc. now owns 18,143 shares of the insurance provider’s stock worth $3,652,000 after acquiring an additional 130 shares during the last quarter. Finally, Trillium Asset Management LLC raised its stake in Allstate by 6.8% during the second quarter. Trillium Asset Management LLC now owns 1,500 shares of the insurance provider’s stock worth $302,000 after purchasing an additional 95 shares during the period. Institutional investors and hedge funds own 76.47% of the company’s stock.

Key Stories Impacting Allstate

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Goldman Sachs reaffirmed its “neutral” rating and set a $231 price target (about a mid‑single‑digit to low double‑digit upside from current levels), which supports near‑term valuation and could limit downside if fundamentals remain intact. Read More.
• Neutral Sentiment: Bloomberg Law reports the privacy case has been narrowed, which may reduce the scope of potential liability depending on further rulings — a development investors should watch for updates. Read More.
• Neutral Sentiment: An Argus analyst report on Allstate is available; investors should review the research for detail on underwriting, reserve, and capital assumptions but the published item itself did not add clear directional news. Read More.
• Negative Sentiment: Reuters reports a court has ruled Allstate must face a privacy lawsuit alleging it tracked drivers via cellphone data — this raises legal, regulatory and reputational risk that could lead to damages, higher compliance costs, or insurer/customer pushback. Read More.
• Negative Sentiment: Coverage (Yahoo/other outlets) highlights investor scrutiny of Allstate’s telematics and data practices — questions about whether data was used to raise premiums or sold to third parties amplify regulatory and reputational concerns. Read More.
• Negative Sentiment: Popular press reports allege the tracked data was used to adjust premiums or deny coverage and sold to other insurers, which, if proven, could increase litigation exposure and harm customer trust. Read More.
• Negative Sentiment: Market reaction: Zacks noted ALL declined more than the broader market in the last session, reflecting investor concern about the headlines and giving short‑term pressure on the stock. Read More.

About Allstate

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.